SCHEMBL12448055

SCHEMBL12448055

CCCCCCCC/C=C\CCCCCCCCC(CCCCCC/C=C\CCCCCCCC)C(=O)O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TERT O14746 3/20 0.58
▸ PTPN1 P18031 3/20 0.58
▸ PPARG P37231 3/20 0.58
▸ PPARD Q03181 3/20 0.58
▸ PPARA Q07869 3/20 0.58
▸ TOP1 P11387 3/20 0.58
▸ MAPT P10636 2/20 0.58
▸ BLM P54132 2/20 0.58
▸ HSD17B10 Q99714 2/20 0.58
▸ FABP4 P15090 2/20 0.58
▸ GMNN O75496 1/20 0.58
▸ USP2 O75604 1/20 0.58
▸ LMNA P02545 1/20 0.58
▸ CYP1A2 P05177 1/20 0.58
▸ POLB P06746 1/20 0.58
▸ CYP2C9 P11712 1/20 0.58
▸ ALOX15 P16050 1/20 0.58
▸ APEX1 P27695 1/20 0.58
▸ CYP2C19 P33261 1/20 0.58
▸ RECQL P46063 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL502596 1.00 TERT (0.58) TERTPTPN1PPARGPPARDPPARA
SCHEMBL150429 1.00 TERT (0.58) TERTPTPN1PPARGPPARDPPARA
SCHEMBL9224800 1.00 TERT (0.58) TERTPTPN1PPARGPPARDPPARA
SCHEMBL2212783 1.00 TERT (0.58) TERTPTPN1PPARGPPARDPPARA
SCHEMBL25292067 1.00 TERT (0.58) TERTPTPN1PPARGPPARDPPARA
SCHEMBL25286066 1.00 TERT (0.58) TERTPTPN1PPARGPPARDPPARA
SCHEMBL4349650 1.00 TERT (0.58) TERTPTPN1PPARGPPARDPPARA
SCHEMBL18114511 1.00 TERT (0.58) TERTPTPN1PPARGPPARDPPARA
SCHEMBL2212781 1.00 TERT (0.58) TERTPTPN1PPARGPPARDPPARA
SCHEMBL5515352 1.00 TERT (0.58) TERTPTPN1PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118922168-A Sun cream additive 西姆莱斯股份公司 2024-11-08 — — CN disclosed
CN-118891030-A Hair care compositions 西姆莱斯股份公司 2024-11-01 — — CN disclosed
EP-3394080-B1 LIPID-LINKED PRODRUGS UNIV BRITISH COLUMBIA (CA) 2023-06-07 — — EP disclosed
US-11541010-B2 Amphoteric liposomes comprising imino lipids BIONTECH DELIVERY TECHNOLOGIES GMBH (DE) 2023-01-03 — — US disclosed
US-11495247-B2 Recording device, reading device, recording method, recording program, reading method, reading program, and magnetic tape FUJIFILM CORPORATION (JP) 2022-11-08 — — US disclosed
US-11373674-B2 Recording device, reading device, recording method, recording program, reading method, reading program, and magnetic tape FUJIFILM CORPORATION (JP) 2022-06-28 — — US disclosed
US-20200330384-A1 AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS BIONTECH DELIVERY TECHNOLOGIES GMBH (DE) 2020-10-22 — — US disclosed
US-10039714-B2 Imino compounds for amphoteric liposomes and uses thereof NOVOSOM VERWALTUNGS GMBH (DE) 2018-08-07 — — US disclosed
US-20160338957-A1 IMINO COMPOUNDS FOR AMPHOTERIC LIPOSOMES AND USES THEREOF BIONTECH PROTEIN THERAPEUTICS GMBH (DE) 2016-11-24 — — US disclosed
US-20160338957-A1 IMINO COMPOUNDS FOR AMPHOTERIC LIPOSOMES AND USES THEREOF BIONTECH PROTEIN THERAPEUTICS GMBH (DE) 2016-11-24 — — US disclosed
EP-2823810-A1 Amphoteric liposomes comprising imino lipids Marina Biotech, Inc. (US) 2015-01-14 — — EP disclosed
EP-2451440-B1 AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS MARINA BIOTECH INC (US) 2014-11-12 — — EP disclosed
US-20120237589-A1 AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS MARINA BIOTECH, INC. (US) 2012-09-20 — — US disclosed
US-20120237589-A1 AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS MARINA BIOTECH, INC. (US) 2012-09-20 — — US disclosed
WO-2011003834-A1 AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS MARINA BIOTECH, INC. (US) 2011-01-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160338957-A1 IMINO COMPOUNDS FOR AMPHOTERIC LIPOSOMES AND USES THEREOF IPO8, IPO7, PHOSPHO1 TERT 2668/4885PTPN1 3721/4885PPARG 3755/4885
US-11541010-B2 Amphoteric liposomes comprising imino lipids SGMS1, SGMS2, PHOSPHO1 TERT 3542/4885PTPN1 3336/4885PPARG 3547/4885
US-20120237589-A1 AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS SGMS1, SGMS2, PHOSPHO1 TERT 3542/4885PTPN1 3336/4885PPARG 3547/4885
US-10039714-B2 Imino compounds for amphoteric liposomes and uses thereof IPO8, IPO7, PHOSPHO1 TERT 2668/4885PTPN1 3721/4885PPARG 3755/4885
US-20200330384-A1 AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS SGMS1, SGMS2, PHOSPHO1 TERT 3542/4885PTPN1 3336/4885PPARG 3547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback